These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 17346304

  • 1. A randomized, double-blind, placebo-controlled study of venlafaxine XR in out-patients with tension-type headache.
    Zissis NP, Harmoussi S, Vlaikidis N, Mitsikostas D, Thomaidis T, Georgiadis G, Karageorgiou K.
    Cephalalgia; 2007 Apr; 27(4):315-24. PubMed ID: 17346304
    [Abstract] [Full Text] [Related]

  • 2. Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
    Hewett K, Chrzanowski W, Schmitz M, Savela A, Milanova V, Gee M, Krishen A, Millen L, Leary MO, Modell J.
    J Psychopharmacol; 2009 Jul; 23(5):531-8. PubMed ID: 18635695
    [Abstract] [Full Text] [Related]

  • 3. Randomized placebo-controlled trial of escitalopram and venlafaxine XR in the treatment of generalized anxiety disorder.
    Bose A, Korotzer A, Gommoll C, Li D.
    Depress Anxiety; 2008 Jul; 25(10):854-61. PubMed ID: 18050245
    [Abstract] [Full Text] [Related]

  • 4. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
    Perahia DG, Pritchett YL, Kajdasz DK, Bauer M, Jain R, Russell JM, Walker DJ, Spencer KA, Froud DM, Raskin J, Thase ME.
    J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831
    [Abstract] [Full Text] [Related]

  • 5. Botulinum toxin a in the treatment of chronic tension-type headache with cervical myofascial trigger points: a randomized, double-blind, placebo-controlled pilot study.
    Harden RN, Cottrill J, Gagnon CM, Smitherman TA, Weinland SR, Tann B, Joseph P, Lee TS, Houle TT.
    Headache; 2009 May; 49(5):732-43. PubMed ID: 19178577
    [Abstract] [Full Text] [Related]

  • 6. Treatment of chronic tension-type headache with botulinum toxin A: a randomized, double-blind, placebo-controlled multicenter study.
    Schulte-Mattler WJ, Krack P, BoNTTH Study Group.
    Pain; 2004 May; 109(1-2):110-4. PubMed ID: 15082132
    [Abstract] [Full Text] [Related]

  • 7. Botulinum toxin type A in the prophylactic treatment of chronic tension-type headache: a multicentre, double-blind, randomized, placebo-controlled, parallel-group study.
    Silberstein SD, Göbel H, Jensen R, Elkind AH, Degryse R, Walcott JM, Turkel C.
    Cephalalgia; 2006 Jul; 26(7):790-800. PubMed ID: 16776693
    [Abstract] [Full Text] [Related]

  • 8. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
    Aurora SK, Gawel M, Brandes JL, Pokta S, Vandenburgh AM, BOTOX North American Episodic Migraine Study Group.
    Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
    [Abstract] [Full Text] [Related]

  • 9. Effect of acupuncture-like electrical stimulation on chronic tension-type headache: a randomized, double-blinded, placebo-controlled trial.
    Wang K, Svensson P, Arendt-Nielsen L.
    Clin J Pain; 2007 May; 23(4):316-22. PubMed ID: 17449992
    [Abstract] [Full Text] [Related]

  • 10. The effect of venlafaxine on ongoing and experimentally induced pain in neuropathic pain patients: a double blind, placebo controlled study.
    Yucel A, Ozyalcin S, Koknel Talu G, Kiziltan E, Yucel B, Andersen OK, Arendt-Nielsen L, Disci R.
    Eur J Pain; 2005 Aug; 9(4):407-16. PubMed ID: 15979021
    [Abstract] [Full Text] [Related]

  • 11. Improvement of psychic and somatic symptoms in adult patients with generalized anxiety disorder: examination from a duloxetine, venlafaxine extended-release and placebo-controlled trial.
    Nicolini H, Bakish D, Duenas H, Spann M, Erickson J, Hallberg C, Ball S, Sagman D, Russell JM.
    Psychol Med; 2009 Feb; 39(2):267-76. PubMed ID: 18485261
    [Abstract] [Full Text] [Related]

  • 12. Headache classification by history has only limited predictive value for headache episodes treated in controlled trials with OTC analgesics.
    Diener HC, Pfaffenrath V, Pageler L, Peil H, Aicher B, Lipton RB.
    Cephalalgia; 2009 Feb; 29(2):188-93. PubMed ID: 18823361
    [Abstract] [Full Text] [Related]

  • 13. Prevalence of migraine and response to sumatriptan in patients self-reporting tension/stress headache.
    Kaniecki R, Ruoff G, Smith T, Barrett PS, Ames MH, Byrd S, Kori S.
    Curr Med Res Opin; 2006 Aug; 22(8):1535-44. PubMed ID: 16870078
    [Abstract] [Full Text] [Related]

  • 14. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R, Schreiber C.
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [Abstract] [Full Text] [Related]

  • 15. Effect of the antidepressant venlafaxine in functional dyspepsia: a randomized, double-blind, placebo-controlled trial.
    van Kerkhoven LA, Laheij RJ, Aparicio N, De Boer WA, Van den Hazel S, Tan AC, Witteman BJ, Jansen JB.
    Clin Gastroenterol Hepatol; 2008 Jul; 6(7):746-52; quiz 718. PubMed ID: 18424191
    [Abstract] [Full Text] [Related]

  • 16. Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study.
    Landau CJ, Carr WD, Razzetti AJ, Sessler NE, Munera C, Ripa SR.
    Clin Ther; 2007 Oct; 29(10):2179-93. PubMed ID: 18042474
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of lacosamide in diabetic neuropathic pain: an 18-week double-blind placebo-controlled trial of fixed-dose regimens.
    Wymer JP, Simpson J, Sen D, Bongardt S, Lacosamide SP742 Study Group.
    Clin J Pain; 2009 Jun; 25(5):376-85. PubMed ID: 19454870
    [Abstract] [Full Text] [Related]

  • 18. Memantine for prophylaxis of chronic tension-type headache--a double-blind, randomized, crossover clinical trial.
    Lindelof K, Bendtsen L.
    Cephalalgia; 2009 Mar; 29(3):314-21. PubMed ID: 19220313
    [Abstract] [Full Text] [Related]

  • 19. Treatment of chronic tension-type headache with botulinum toxin: a double-blind, placebo-controlled clinical trial.
    Padberg M, de Bruijn SF, de Haan RJ, Tavy DL.
    Cephalalgia; 2004 Aug; 24(8):675-80. PubMed ID: 15265057
    [Abstract] [Full Text] [Related]

  • 20. Extended-release formulation of venlafaxine in the treatment of post-traumatic stress disorder.
    Pae CU, Lim HK, Ajwani N, Lee C, Patkar AA.
    Expert Rev Neurother; 2007 Jun; 7(6):603-15. PubMed ID: 17563244
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.